Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Some Teenagers Recreated Martin Shkreli's Crazy-Expensive Drug For $20

Huffington Post Thursday, 1 December 2016
When Martin Shkreli, the former CEO of Turing Pharmaceuticals, hiked up the price of a life-saving medication, one group of high school students saw an opportunity to do good.

Eight teenagers from Sydney Grammar School in Australia have collaborated with scientists from the University of Sydney to reproduce the active...
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Newsy Studio - < > Embed

News video: Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose

Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose 01:16

A group of Australian students say they recreated the active ingredient in life-saving drug Daraprim for a fraction of its U.S. price.

Recent related news

Lil Wayne Will Sue Martin Shkreli If 'Carter 5' Leaks Again

Lil Wayne is demanding Martin Shkreli hand over his copy of "Tha Carter V" and says if the infamous disgraced pharma exec leaks anymore of it online ... he's...
TMZ.com - CelebritiesAlso reported by •Perez Hilton

You Might Like


Other recent news in World

Russian ambassador told Moscow that KUSHNER wanted secret communications channel with KremlinIf FBI wants to talk to JARED KUSHNER about Russian contacts, lawyer says he's ready
Exams in RAMADAN: What should I eat?SRI LANKA floods: Scores die as monsoons trigger mudslides
ZBIGNIEW BRZEZINSKI, Carter's national security adviser, dies at 89ARIANA GRANDE to play a benefit concert for victims in bombing
HILLARY CLINTON rips into Trump at university addressMELANIA TRUMP changes into a silver gown for G7 concert
South Carolina man who chained woman in shipping container PLEADS GUILTY to killing 7Melania Trump’s pricey jacket draws attention in SICILY

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+